Epstein Secrets

ts higher at 28,363.66, the S&P 500 added 17.93 points to close at 3,453.49, and the Nasdaq climbed 21.31 points to 11,506.01. The AR (10/22, Choe, Troise, Veiga) and the Wall Street Journal (10/22, Bartholomew, Eisen, Subscription Publication, 7.57M), and Bloomberg (10/22, Haigh, 4.73M) provide simil

WHO study, which was not 'blinded,' meaning that participants and their doctors were aware of which treatments were being used." Bloomberg (10/22, Langreth, 4.73M) reports the approval also allows "Gilead to market the drug and talk about its benefits to doctors, nurses, and patients. That could help so

1,506.01. The AP <https://www.usatoday.com/story/money/2020/10/22/us-stocks-flip-flop-amid-profit-reports-stimulus- talks/3727449001/> (10/22, Choe, Troise, Veiga) and the Wall Street Journal <https://www.wsj.com/articles/global-stock-markets-dow-update-10-22-2020-11603358278> (10/22, Bartholomew, Eise

used." Bloomberg <https://www.bloomberg.cotn/news/articles/2020-10-22/gilead-virus-therapy-remdesivir-gains- approval-from-fda?srnd-premium> (10/22, Langreth, 4.73M) reports the approval also allows "Gilead to market the drug and talk about its benefits to doctors, nurses, and patients. That could help so

nts higher at 28,363.66, the S&P 500 added 17.93 points to close at 3,453.49, and the Nasdaq climbed 21.31 points to 11,506.01. The AP (10/22, Choe, Troise, Veiga) and the Wall Street Journal (10/22, Bartholomew, Eisen, Subscription Publication, 7.57M), and Bloomberg (10/22, Haigh, 4.73M) provide simila

WHO study, which was not `blinded,' meaning that participants and their doctors were aware of which treatments were being used." Bloomberg (10/22, Langreth, 4.73M) reports the approval also allows "Gilead to market the drug and talk about its benefits to doctors, nurses, and patients. That could help so